Semaglutide is a GLP-1 receptor agonist used in medical treatment under prescription
Microgreens on the rise: Expanding our horizons from farm to fork
Physicians should avoid prescribing it to: Patients with a history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN2). Individuals with severe gastrointestinal conditions, such as gastroparesis. Patients with a known allergy to GLP-1 receptor agonists. Pregnant or breastfeeding women, unless approved by a physician
The NAC + Glycine Synergy A growing number of studies now point to a breakthrough: NAC + Glycine, or GlyNAC, a clinically validated blend that elevates NACs antioxidant potential
However, some users also report mild fatigue, mood swings, and sleep disruptions, even though these are less common than gastrointestinal side effects
Main approaches for delivering antioxidant vitamins through the skin to prevent skin ageing